Eyenuk
SF 7.9AI retinal screening across multiple eye diseases
AI retinal screening across multiple eye diseases
Autonomous AI for diabetic retinopathy screening
Quick decision guide
Not enough differentiated product data yet to make a strong automatic pick.
Overview
Eyenuk is an AI retinal-screening platform for primary care and organized screening programs, detecting diabetic retinopathy, diabetic macular edema, and related retinal conditions.
Eyenuk is best evaluated as a screening layer whose value depends on workflow placement, specialist follow-up, and coordinated deployment across participating sites.
Digital Diagnostics develops autonomous AI retinal screening technology for primary care sites, with IDx-DR screening retinal images for diabetic retinopathy.
Its suitability depends on condition-specific authorization, image-capture quality, dependable referral pathways, and operational adoption across participating primary care teams.
Side-by-side
OVERLAP
Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.
Shared capabilities
Shared workflows
Feature check
The trade-offs
Final verdict
Current catalog data shows meaningful overlap between Eyenuk and Digital Diagnostics. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.
Eyenuk and Digital Diagnostics share 10 catalog signals, so the decision should focus on fit rather than broad capability alone.
Eyenuk has 3 visible decision signals and Digital Diagnostics has 3.
Digital Diagnostics has the higher SoftFinders Score in the current catalog data.